The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences

Douglas A. Luke, Cathy C. Sarli, Amy M. Suiter, Bobbi J. Carothers, Todd B. Combs, Jae L. Allen, Courtney E. Beers, Bradley A. Evanoff

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in-house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.

Original languageEnglish
Pages (from-to)77-84
Number of pages8
JournalClinical and translational science
Volume11
Issue number1
DOIs
StatePublished - Jan 2018

Fingerprint Dive into the research topics of 'The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences'. Together they form a unique fingerprint.

Cite this